Mr. Ittai Harel

Pitango Appoints Industry Veteran, Ittai Harel as Venture Partner, Focusing on Investments in Life Sciences

Mr. Ittai Harel, venture partner, Pitango venture capital, has fifteen years of experience in the healthcare field covering a wide range of activities, from basic business and technology development to corporate executive management. Mr. Harel was Director of Corporate Development at Nektar Therapeutics (NASDAQ: NKTR). Mr. Harel has a B.Sc. in Chemical Engineering and Biotechnology from Ben Gurion University, as well as an MBA from the MIT Sloan School of Management.

Ittai Harel

Christopher J. Rust, USVP Partner, Jacques Benkoski, USVP Venture Partner and Ittai Harel, Pitango Partner to join BPT's Board
...
In conjunction with this round Christopher J. Rust, USVP Partner and Jacques Benkoski, USVP Venture Partner will represent USVP on the BPT Board and Ittai Harel, Pitango Partner, will represent Pitango Venture Capital.
...
Ittai Harel, partner at Pitango Venture Capital, added: "Cleantech is an area of growing concern to the world market.

Ittai Harel

Ittai Harel Pitango Venture Capital - Ittai Harel

Pitango Venture Capital
...
Ittai Harel | Partner

Pitango Team Members:

Mr. Harel is a veteran of the life sciences industry. He has fifteen years of experience in this field covering a wide range of activities, from basic business and technology development to corporate executive management, in areas such as pharmaceutical development, drug delivery, medical devices and diagnostics.

Before joining Pitango, Mr. Harel was Director of Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) where he was responsible for strategic planning, in-licensing and M&A activities. Prior to his period with Nektar, Mr. Harel held various management positions at large companies both in Israel and in the U.S. including IDEXX Laboratories (NASDAQ: IDXX) and IDGene Pharmaceuticals.

Mr. Harel has a B.Sc. in Chemical Engineering and Biotechnology from

Pitango Appoints Industry Veteran, Ittai Harel as Venture Partner, Focusing on Investments in Life Sciences

August 13, 2006.

Pitango Venture Capital, a leading venture capital firm in Israel, today announced that Ittai Harel has been appointed as a Venture Partner.Mr. Harel is a veteran of the life sciences industry.He has fifteen years of experience in this field covering a wide range of activities, from basic business and technology development to corporate executive management, in areas such as pharmaceutical development, drug delivery, medical devices and diagnostics.

Before joining Pitango, Mr. Harel was Director of Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) where he was responsible for strategic planning, in-licensing and M&A activities.Prior to his period with Nektar, Mr. Harel held various management positions at large companies both in Israel and in the U.S. including IDEXX Laboratories (NASDAQ: IDXX) and IDGene Pharmaceuticals.

Mr. Harel has a B.Sc. in Chemical Engineering and Biotechnology from Ben Gurion University, as well as an MBA from the MIT Sloan School of Management.

"Ittai brings vast industry experience, technological expertise and business acumen in the life sciences industry to Pitango," says Rami Kalish, Managing General Partner and Co-Founder.
...
"With Ittai on board, we have added to the breadth of our team of investment professionals in the Life Sciences sector.
...
"I am delighted to be joining the exceptional team of Pitango", says Ittai Harel.

Pitango Appoints Industry Veteran, Ittai Harel as Venture Partner, Focusing on Investments in Life Sciences